ETD001C clinical trials

A Randomised, Double-Blind, Placebo Controlled, Two-Part Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Repeat Dose of Inhaled ETD001 in People with Cystic Fibrosis

This study is testing a new inhaled medicine, ETD001, for people with cystic fibrosis. It aims to see if it's safe, how well it works, and how the body handles it. Some people will get the medicine, others a dummy treatment.